Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
4
self-reported 2–10 band
Founded
2008
18 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Nonprofit
self-reported
Legal entity
1 brand → 1 confirmed entity
Brain Tumour Alliance Australia
ABN97733801179
Legal entities
Show as table · Brain Tumour Alliance Australia: 1 registry entity
| Brain Tumour Alliance Australia | ABN 97733801179 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Brain Tumour Alliance Australia unites and strengthens the voices of the brain tumour community to drive better outcomes for all affected.
As the peak brain tumour advocacy body, we support, inform, and represent people living with brain tumours, their families, care givers, and the professionals who care for them. We connect people, organisations, and government to foster collaboration and build awareness. We educate the community and inform decision-makers to shape policy and better outcomes. By uniting lived experience with expertise, we champion the needs of the brain tumour community to achieve lasting improvements in research, clinical care and support.
Our Vision A future where every person affected by a brain tumour is educated, empowered, and supported with the best possible care.
Brain Tumour Alliance Australia envisions a community strengthened by knowledge and collaboration, enabled by equitable access to clinical trials and treatment options, and bolstered by adequate funding and research.
We work toward a future where the burden of disease is reduced, and patients, families, and caregivers experience optimal outcomes.
BTAA is a not-for-profit organisation and supports patients with any brain tumour (neoplasm) affecting the central nervous system (CNS), which includes the meninges, brain, and spinal cord. Our support includes both paediatric and adult tumours, malignant and benign tumours, and metastatic brain tumours.
BTAA believes that brain tumours represent a neglected illness, which places enormous challenges on the patient and family and requires a unique response, and a much-increased research effort supported by the community and governments.
BTAA has a broad membership and subscriber database that includes health professionals and academics with a particular interest in brain tumours.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU1 Collett Place; Pearce, ACT 2607Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
1 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
Which legal entity operates under Brain Tumour Alliance Australia?
One Australian Capital Territory entity on the ABR: Brain Tumour Alliance Australia (ABN 97 733 801 179), high confidence.
How many people work at Brain Tumour Alliance Australia?
4 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Brain Tumour Alliance Australia have offices?
One address on record, Australia only. Primary: 1 Collett Place, Pearce, ACT 2607.
Has Brain Tumour Alliance Australia raised funding?
None linked to this brand.
Which companies are listed alongside Brain Tumour Alliance Australia?
Seven peer profiles on record: COGNO - Cooperative Trials Group for Neuro-Oncology and Mark Hughes Foundation Centre for Brain Cancer Research.